Urolog. pro Praxi, 2003; 5: 208-212 [Interní Med. 2002; 4(10): 494-498]

Hojení ran za patologických podmínek

MUDr. Martin Wald
Chirurgická klinika UK 2. LF a FN Motol, Praha

Keywords: wound healing, systemic impairments, pharmacological support, systemic enzyme therapy.

Published: December 31, 2003  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Wald M. Hojení ran za patologických podmínek. Urol. praxi. 2003;4(5):208-212.

Článek se zabývá problematikou hojení ran. V prvé části stručně popisuje fyziologii hojení, ve druhé části pak nejčastější lokální a systémové příčiny poruch hojení ran. Jejich znalost je předpokladem správné diferenciální diagnózy, a to nejen při již vzniklé poruše hojení, nýbrž i pro její optimální a účinnou prevenci (chirurgické výkony u rizikových pacientů). Ve třetí části zmiňuje farmakologickou podporu hojení s důrazem na použití léků ze skupiny systémové enzymoterapie.

Wound healing under pathological conditions

The article concerns about healing of wounds. In the first part, a physiology of healing is described, whereas in the second part, most frequent local and systemic causes of wound healing impairments are mentioned. Their knowledge is necessary for a correct differential diagnosis not only in case of already developed healing impairment, but also enables an optimal and effective prevention (surgical interventions in risk patients). In the third part, a pharmacological support of healing is described. Systemic enzyme therapy and its options are stressed.

Download citation

References

  1. Desser L, Herbacek I, Zavadova E, and Mohr T. Conversion of ?2Macroglobulin (2M) to the fast-form by Wobenzym(R) interrupts the autocrine loop of TGF? production in melanoma cells. The European Journal of Cancer 1999; 4: 1526. Go to original source...
  2. Ernst E. Oral therapy with proteolytic enzymes: Effects on hemorheological parameters. Perfusion 1994; 12: 440-441.
  3. Heinz R. Erste Erfahrungen in der Therapie diabetischer Angiopathien mit dem hydrolytischen Enzympräparat Wobenzym(R). Arzt und Praxis 1996; 745: 3-6.
  4. Hofstädter F. Pathologie der Wundheilung. Chirurg 1995; 66: 174-181. Go to PubMed...
  5. Lawrence WW, et al. Současná chirurgická diagnostika a léčba. Grada Publishing 1998.
  6. Luerti M, Vignali ML. Influence of Bromelain on Penetration of Antibiotics in Uterus, Salpinx and Ovary. Drugs exptl clin res 1978; 1: 45-48.
  7. Mast BA, Diegelman RF, Krummel TM, Cohen IK. Scarless wound healing in the mammalian fetus. Surg Gynecol Obstet 1992; 174: 441.
  8. Muselmann E, Weissenbacher ER, Goetz A, Braun P, Weinmeyer W, Buschmans E, Fruth C. Enzyme therapy for the prevention of episiotomy pain. International Journal of Feto-Maternal Medicine 1993; Vol. 6, Suppl. 3.
  9. Müller M, et al. Chirurgie pro studium a praxi. Goldstein & Goldstein, Praha 1997.
  10. Nečas E, et al. Obecná patologická fyziologie. Karolinum 2000.
  11. Nouza K, Olejár T, Nouza M. Proteases in the control and modulation of immunity. Klinická imunológia a alergológia 1999, 3: 22-27.
  12. O´Meara SM, Cullum NA, Majid M, et al. Systemic review of antimicrobial agents used for chronic wounds. British Journal of Surgery 2001; 1: 4-21. Go to original source... Go to PubMed...
  13. Resl V. Hojení chronických ran. Grada Publishing 1997.
  14. Saradeth T, Quittan M, Ghanewm AH, Ernst E. Improvement in blood fluidity characteristics via Phlogenzym. Perfusion 1995: 196-198.
  15. Shah M, Foreman DM, Ferguson MW. Centro of scaring in adult wounds by neutralising antibody to transformin gowth factor beta. Lancet 1992; 339: 213. Go to original source... Go to PubMed...
  16. Schwemmle K, Linder R. Prinzipien der primären und sekundären Wundversorgung. Chirurg 1995; 66: 182-187. Go to PubMed...
  17. Wald M. Sekundární lymfedém po onkochirurgické terapii. Interní medicína pro praxi 2002; 5: 210-214.




Urology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.